-
1
-
-
30044433616
-
Autoimmune hepatitis
-
Krawitt EL. Autoimmune hepatitis. N Engl J Med 2006; 354: 54-66.
-
(2006)
N Engl J Med
, vol.354
, pp. 54-66
-
-
Krawitt, E.L.1
-
2
-
-
41349118815
-
Three cases of autoimmune hepatitis in HIV-infected patients
-
Puius YA, Dove LM, Brust DG, Shah DP, Lefkowitch JH. Three cases of autoimmune hepatitis in HIV-infected patients. J Clin Gastroenterol 2008; 42: 425-429.
-
(2008)
J Clin Gastroenterol
, vol.42
, pp. 425-429
-
-
Puius, Y.A.1
Dove, L.M.2
Brust, D.G.3
Shah, D.P.4
Lefkowitch, J.H.5
-
5
-
-
0023813026
-
Human immunodeficiency virus infection mimics autoimmune hepatitis-A case report
-
Ramadori G, Lohr H, Rossol S, Manns M, Meyer zum Buschenfelde KH. Human immunodeficiency virus infection mimics autoimmune hepatitis-A case report. Klin Wochenschr 1988; 66: 1040.
-
(1988)
Klin Wochenschr
, vol.66
, pp. 1040
-
-
Ramadori, G.1
Lohr, H.2
Rossol, S.3
Manns, M.4
Meyer zum Buschenfelde, K.H.5
-
6
-
-
33646547657
-
Autoimmune hepatitis in a HIV-HCV co-infected patient: Diagnostic and therapeutic difficulties]
-
Cazanave C, Rakotondravelo S, Morlat P, et al. [Autoimmune hepatitis in a HIV-HCV co-infected patient: Diagnostic and therapeutic difficulties]. Rev Med Interne 2006; 27: 414-419.
-
(2006)
Rev Med Interne
, vol.27
, pp. 414-419
-
-
Cazanave, C.1
Rakotondravelo, S.2
Morlat, P.3
-
7
-
-
44349103597
-
Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient
-
Coriat R, Podevin P. Fulminant autoimmune hepatitis after successful interferon treatment in an HIV-HCV co-infected patient. Int J STD AIDS 2008; 19: 208-210.
-
(2008)
Int J STD AIDS
, vol.19
, pp. 208-210
-
-
Coriat, R.1
Podevin, P.2
-
8
-
-
0024386270
-
Hazards of interferon therapy for HBV-seronegative chronic hepatitis
-
Vento S, Di Perri G, Garofano T, et al. Hazards of interferon therapy for HBV-seronegative chronic hepatitis. Lancet 1989; 2: 926.
-
(1989)
Lancet
, vol.2
, pp. 926
-
-
Vento, S.1
Di Perri, G.2
Garofano, T.3
-
9
-
-
34548479023
-
Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment
-
Kogure T, Ueno Y, Fukushima K, et al. Fulminant hepatic failure in a case of autoimmune hepatitis in hepatitis C during peg-interferon-alpha 2b plus ribavirin treatment. World J Gastroenterol 2007; 13: 4394-4397.
-
(2007)
World J Gastroenterol
, vol.13
, pp. 4394-4397
-
-
Kogure, T.1
Ueno, Y.2
Fukushima, K.3
-
10
-
-
0032718310
-
International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis
-
Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
-
(1999)
J Hepatol
, vol.31
, pp. 929-938
-
-
Alvarez, F.1
Berg, P.A.2
Bianchi, F.B.3
-
11
-
-
1542283730
-
Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection
-
De Milito A, Nilsson A, Titanji K, et al. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 2004; 103: 2180- 2186.
-
(2004)
Blood
, vol.103
, pp. 2180-2186
-
-
De Milito, A.1
Nilsson, A.2
Titanji, K.3
-
12
-
-
33845458012
-
Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis
-
Frenzel C, Herkel J, Luth S, et al. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis. Am J Gastroenterol 2006; 101: 2731-2736.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 2731-2736
-
-
Frenzel, C.1
Herkel, J.2
Luth, S.3
-
13
-
-
34547465111
-
Prevalence of IgG autoantibody against F-actin in patients suspected of having autoimmune or acute viral hepatitis
-
Jaskowski TD, Konnick EQ, Ashwood ER, Litwin CM, Hill HR. Prevalence of IgG autoantibody against F-actin in patients suspected of having autoimmune or acute viral hepatitis. J Clin Lab Anal 2007; 21: 249-253.
-
(2007)
J Clin Lab Anal
, vol.21
, pp. 249-253
-
-
Jaskowski, T.D.1
Konnick, E.Q.2
Ashwood, E.R.3
Litwin, C.M.4
Hill, H.R.5
-
14
-
-
32844472073
-
Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus
-
Cholongitas E, Samonakis D, Patch D, et al. Induction of autoimmune hepatitis by pegylated interferon in a liver transplant patient with recurrent hepatitis C virus. Transplantation 2006; 81: 488-490.
-
(2006)
Transplantation
, vol.81
, pp. 488-490
-
-
Cholongitas, E.1
Samonakis, D.2
Patch, D.3
-
15
-
-
33646440159
-
Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation
-
Kontorinis N, Agarwal K, Elhajj N, Fiel MI, Schiano TD. Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation. Liver Transpl 2006; 12: 827-830.
-
(2006)
Liver Transpl
, vol.12
, pp. 827-830
-
-
Kontorinis, N.1
Agarwal, K.2
Elhajj, N.3
Fiel, M.I.4
Schiano, T.D.5
-
16
-
-
33646558624
-
Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected sustained virological responders from nonresponders
-
Talal AH, Ribeiro RM, Powers KA, et al. Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected sustained virological responders from nonresponders. Hepatology 2006; 43: 943-953.
-
(2006)
Hepatology
, vol.43
, pp. 943-953
-
-
Talal, A.H.1
Ribeiro, R.M.2
Powers, K.A.3
-
17
-
-
14944364658
-
Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virusinfected patients
-
Sherman KE, Shire NJ, Rouster SD, et al. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virusinfected patients. Gastroenterology 2005; 128: 313-327.
-
(2005)
Gastroenterology
, vol.128
, pp. 313-327
-
-
Sherman, K.E.1
Shire, N.J.2
Rouster, S.D.3
-
19
-
-
67651170684
-
-
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 29, 2008: 1-128. www.aidsinfo .nih.gov/ContentFiles/AdultandAdolescentGL.pdf (Last accessed June 26, 2008).
-
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 29, 2008: 1-128. www.aidsinfo .nih.gov/ContentFiles/AdultandAdolescentGL.pdf (Last accessed June 26, 2008).
-
-
-
|